Discontinuation report (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP
| Report ID | 257560 |
| Drug Identification Number | 00437999 |
| Brand name | (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP |
| Common or Proper name | ewewe |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | POTASSIUM CHLORIDE SODIUM CHLORIDE DEXTROSE |
| Strength(s) | 150MG 450MG 5G |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 2323 |
| ATC code | B05BB |
| ATC description | I.V. SOLUTIONS |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | 2020-01-01 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-10-14 | French | Compare |
| v1 | 2025-10-14 | English | Compare |
Showing 1 to 2 of 2